Hematology News and Research

RSS

Hematology, also spelled haematology, is the branch of biology (physiology), pathology, clinical laboratory, internal medicine, and pediatrics that is concerned with the study of blood, the blood-forming organs, and blood diseases. Hematology includes the study of etiology, diagnosis, treatment, prognosis, and prevention of blood diseases.

Women with breast cancer face very unique challenges

Will I be able to have a baby? Will the treatment trigger early menopause? What about my sex life? Women under 40 who are diagnosed with breast cancer face some very unique challenges.

3 Oct 2019

Findings could open up new research avenues into how heme tolerance occurs in humans

Most people have some idea of how important iron is to their health, but Iqbal Hamza, professor in Animal and Avian Sciences, has made his seventeen-year career at the University of Maryland all about the study of iron and heme trafficking and regulation in the body.

1 Oct 2019

Detecting neurocognitive change in children with acute lymphoblastic leukemia

Although cure rates for children with cancer are increasing, cancer treatments can cause permanent deterioration of brain functions leading to impairments in attention, concentration, memory and learning. As a result, these changes can lead to challenges with school, obtaining future employment and overall quality of life into adulthood, even though cancer treatment may have been successful.

1 Oct 2019

'Good' cholesterol reverses atherosclerosis in the blood vessels of mice with diabetes

Increasing levels of a simplified version of "good" cholesterol reversed disease in the blood vessels of mice with diabetes, a new study finds.

30 Sep 2019

Adding targeted therapy drug to standard treatment benefits aggressive breast cancer patients

A study led by UCLA researchers found that adding ribociclib, a targeted therapy drug, to standard hormone therapy has been shown to significantly improve overall survival in postmenopausal women with advanced hormone-receptor positive/HER2- breast cancer, one of the most common forms of the disease.

29 Sep 2019

Children's of Alabama using cold sore virus to fight pediatric brain cancer

Children's of Alabama is home to one of the most exciting studies underway in pediatric cancer: evaluating the use of a cold sore virus to treat children with progressive malignant brain tumors.

26 Sep 2019

Oncologists respond quickly to emerging FDA safety data for drugs, study finds

Within six months of the U.S. Food and Drug Administration's move to restrict the label of two immunotherapies, usage of those therapies among oncologists dropped by about 50 percent, according to a new study from researchers in the Abramson Cancer Center at the University of Pennsylvania.

24 Sep 2019

Researchers explore risk of ALL in children with Down syndrome

Acute lymphoblastic leukemia (ALL), is the most common childhood cancer. Children with trisomy 21 (Down syndrome) are 10 to 20 times more likely to develop ALL than children without Down syndrome.

24 Sep 2019

Discovery of combination protein leads to first-in-human clinical trial for leukemia

The discovery of tri-specific natural killer engagers (TriKE™), a combination protein that bridges an immune cell and a tumor cell to drive tumor cell killing power exponentially, has led to a new Phase I, first-in-human study to treat leukemia.

20 Sep 2019

Scientists design new model for predicting what might make an effective cancer vaccine

Scientists at the University of North Carolina Lineberger Comprehensive Cancer Center have designed and validated a model for predicting what might make an effective cancer vaccine against a patient's tumor.

13 Sep 2019

Papilloma viruses capable of spreading via blood

Human Papilloma Virus or HPV has been known to be transmitted between humans via sexual contact and HPV has been known to be a sexually transmitted disease or STD. The Centers for Disease Control and Prevention (CDC) states that HPV is one of the commonest STDs among humans.

12 Sep 2019

Mount Sinai awarded $1.7 million to study how bladder cancer affects 'natural killer' cells

The Icahn School of Medicine at Mount Sinai has been awarded nearly $1.7 million in grant funding from the U.S. Department of Defense to study how bladder cancer affects certain types of white blood cells called "natural killer" cells, or NK cells, which control and limit tumor growth.

12 Sep 2019

HORIBA’s Yumizen hematology analyzers minimize microscopy slide reviews, improve diagnosis

HORIBA UK Ltd, Medical announces the publication of scientific studies which demonstrate the excellent performance of its new HELO high throughput fully automated haematology platform on body fluid and pathological samples.

From HORIBA Scientific UK 11 Sep 2019

Age affects efficacy of immunotherapy treatment for breast cancer, preclinical study reveals

Recent clinical trials have indicated that immune checkpoint blockade (ICB) therapy, which is designed to unleash a patient's immune system to attack cancer, has been revolutionary in its implications for breast cancer treatment, especially for its potential to treat patients with triple negative breast cancer.

8 Sep 2019

Childhood cancer survivors have higher risk of developing heart disease

Survivors of childhood cancer have a higher risk of developing a range of heart disease due to cancer therapy, according to new research published in the American Heart Association's journal Circulation.

26 Aug 2019

New therapy found to be effective for patients with a particular type of bone marrow cancer

Mount Sinai researchers have found a new type of therapy to be effective for patients with a particular type of bone marrow cancer that is resistant to several standard therapies, according to results of a clinical trial published in The New England Journal of Medicine in August.

22 Aug 2019

Hematology News and Research

Further Reading

Women with breast cancer face very unique challenges

Findings could open up new research avenues into how heme tolerance occurs in humans

Detecting neurocognitive change in children with acute lymphoblastic leukemia

'Good' cholesterol reverses atherosclerosis in the blood vessels of mice with diabetes

Adding targeted therapy drug to standard treatment benefits aggressive breast cancer patients

Children's of Alabama using cold sore virus to fight pediatric brain cancer

Oncologists respond quickly to emerging FDA safety data for drugs, study finds

Researchers explore risk of ALL in children with Down syndrome

Discovery of combination protein leads to first-in-human clinical trial for leukemia

Scientists design new model for predicting what might make an effective cancer vaccine

Papilloma viruses capable of spreading via blood

Mount Sinai awarded $1.7 million to study how bladder cancer affects 'natural killer' cells

HORIBA’s Yumizen hematology analyzers minimize microscopy slide reviews, improve diagnosis

Age affects efficacy of immunotherapy treatment for breast cancer, preclinical study reveals

Childhood cancer survivors have higher risk of developing heart disease

New therapy found to be effective for patients with a particular type of bone marrow cancer

FDA approves new drug to treat patients with myelofibrosis

Uchicago Medicine oncologist to receive 2019 Henry M. Stratton Medal for hematology research

Newborn mouse model yields clues to cause of devastating gut disease in anemic preemies

People who have a parent, sibling, or child with blood cancer have higher risk of disease

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo